Baisong Lu
Editorial Board Member, Metabolism and Diseases
Wake Forest School of Medicine, Winston-Salem, USA
Wake Forest School of Medicine, Winston-Salem, USA
Field:
1) Genome editing technologies and gene therapy for inherited diseases including Dent’s disease, Friedreich’s ataxia and Duchenne muscular dystrophy;
2) Development of non-viral delivery platforms (virus-like particles, lipid nanoparticles and engineered extracellular vesicles) for safe and efficient CRISPR/Cas9 delivery;
3) Molecular mechanisms underlying neurodevelopment, fertility and peptide/protein-based therapeutics.
Key words:
Gene therapy; Gene editing; Virus-like particles; Lipid nanoparticles; Dent disease; Delivery